openalexFrontiers in Immunology2026-07-24
Anlotinib combined with chemoradiotherapy for postoperative isolated lymph node recurrence of ESCC: a phase II study
Jing Huang, 顾振林, Jinjing Xu, Changhua Yu, W J Zhu, Yiyuan Zhang, et al.
Background Postoperative lymph node recurrence in esophageal squamous cell carcinoma (ESCC) is associated with poor prognosis and lacks standardized treatment. Radioresistance and aberrant immune/inflammatory tumor microenvironment (TME) are major barriers limiting the efficacy o…